Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development.

52W Range

1stpctl

Volume

0.19×avg

Market Cap

3.37MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Cadrenal Therapeutics, Inc. Common Stock

CVKDNASDAQ Global Market·USD·Closed

Cadrenal Therapeutics, Inc. Common Stock

CVKDNASDAQ·USD·Closed

$0.95

+0.60%

$0.95

+$0.01 (0.60%)

52W Range

1stpctl

Volume

0.19×avg

Mkt Cap

3.37MUSD

P/E

-0.2TTM

Div Yield

–ann

CVKD: Cadrenal Therapeutics, Inc. Common Stock Stock Analysis | finqOS